ANXA1 plays a crucial role in the regulation of inflammation and the immune response. It mediates some of the anti-inflammatory effects of glucocorticoids, which are hormones that modulate inflammation and immune responses . The protein is involved in various cellular processes, including:
Given its significant role in inflammation, ANXA1 has been extensively studied for its therapeutic potential in various inflammatory diseases. Research has shown that ANXA1 and its mimetics can effectively limit inflammation in experimental models of myocardial ischemia/reperfusion injury, arthritis, stroke, multiple sclerosis, and sepsis . The protein’s ability to promote the resolution of inflammation makes it a promising target for drug discovery.
Recombinant ANXA1 (Mouse) is a form of the protein that is produced through recombinant DNA technology. This involves inserting the gene encoding ANXA1 into a suitable expression system, such as bacteria or mammalian cells, to produce the protein in large quantities. Recombinant ANXA1 is used in research to study its biological functions and therapeutic potential.